|

Why are tech companies buying healthcare companies?

The convergence of healthcare and digital technologies has gained more momentum in recent years as healthcare firms adapt to the changing ecosystem and as big tech companies see the potential in integrating technologies in the medical sector.

The scale of the global digital health market stood at $175.6 billion in 2021, according to Grand View Research, and is estimated to grow at a compound annual growth rate of 27.7% from 2022 through 2030.

The market research firm attributed the anticipated forecast to increasing smartphone penetration, improving internet connectivity and healthcare IT infrastructure, and the rising prevalence of chronic diseases, among other factors.

In the US alone, the size of the digital health market hit $66.5 billion in 2021 from $55.3 billion in 2020.

The COVID-19 effect

As the COVID-19 pandemic took hold, companies have realized the importance of digital transformation in healthcare in terms of diagnosis, medical records tracking, surveillance and other services from transmission of prescriptions to hospital bedside devices for patient monitoring.

However, a study by the National Academy of Medicine published in January found that the pandemic also revealed limitations to digital health technologies including the need for a coherent and accessible data infrastructure to help address the pandemic.

Those limitations still exist even as a number of tech giants have invested heavily in the healthcare sector.

Apple’s focus on health and fitness

Apple (NASDAQ:AAPL), previously the world's most valuable company before it lost the crown to Saudi Aramco, last week underscored its strong presence in the healthcare market with its devices that are “empowering people with their health information.”

The company continues to roll out new updates for the Apple Watch and the iPhone that are focused on health and fitness. This fall, new updates of the iOS and watchOS will center on 17 areas of health and fitness, from heart health and sleep to mobility and women’s health, the company said.

In 2019, Apple CEO Tim Cook said the company’s health offerings will be “Apple's greatest contribution to mankind.”

Amazon’s new healthcare bet

Amazon.com (NASDAQ:AMZN) also has its share of health investments. The e-commerce and tech giant recently disclosed a $3.9 billion plan to acquire One Medical, a chain of primary care clinics in the US, backed by private equity firm Carlyle Group.

The acquisition marks Amazon’s latest investment in the healthcare sector after launching Amazon Care, a virtual health service, in 2019 to treat its employees and their families. The service offers virtual visits, in-person primary care visits and prescription delivery.

Amazon also bought online pharmacy PillPack in 2018 for $753 million. The service, now called Amazon Pharmacy, delivers medications to customers.

Meanwhile, an analysis by The New York Times suggests that Amazon’s purchase of One Medical would provide Amazon access to more data as the target company has 15 years’ worth of medical and health-system data. The deal has so far been met with criticism including from US Senator Amy Klobuchar, who called on the Federal Trade Commission to “thoroughly investigate” the proposed deal due to anticompetitive concerns.

On the other side of the coin, the big tech giants’ efforts to grab a share of the digital healthcare market could be said to improve health systems globally and helps bridge the gap in data sharing, allowing the healthcare and medical sector including drugmakers to fast-track drug development.

“Rising health-care costs and the shift to new payment models in this $4 trillion market will increase the focus on care outside of traditional settings, which will rely heavily on connected technologies,” Bloomberg Intelligence said in an analysis in March.

Author

Mark O’Donnell

Mark O’Donnell

Blackbull Markets Limited

Mark O’Donnell is a Research Analyst with BlackBull Markets in Auckland, New Zealand.

More from Mark O’Donnell
Share:

Markets move fast. We move first.

Orange Juice Newsletter brings you expert driven insights - not headlines. Every day on your inbox.

By subscribing you agree to our Terms and conditions.

Editor's Picks

EUR/USD clings to small gains near 1.1750

Following a short-lasting correction in the early European session, EUR/USD regains its traction and clings to moderate gains at around 1.1750 on Monday. Nevertheless, the pair's volatility remains low, with investors awaiting this weeks key data releases from the US and the ECB policy announcements.

GBP/USD edges higher toward 1.3400 ahead of US data and BoE

GBP/USD reverses its direction and advances toward 1.3400 following a drop to the 1.3350 area earlier in the day. The US Dollar struggles to gather recovery momentum as markets await Tuesday's Nonfarm Payrolls data, while the Pound Sterling holds steady ahead of the BoE policy announcements later in the week.

Gold holds gains above $4,300 on prospect of further Fed rate cuts

Gold price extends its upside to around $4,305, the highest since October 21, during the early Asian trading hours on Tuesday. The precious metal edges higher on further US Federal Reserve cut bets. The US Nonfarm Payrolls report will take center stage later on Tuesday. Also, the US Retail Sales and Purchasing Managers Index will be published. 

Ethereum: BitMine acquires 102,259 ETH as price plunges 5%

Ethereum treasury company BitMine Immersion scaled up its digital asset stash last week after acquiring 102,259 ETH since its last update. The purchase has increased the company's holdings to 3.96 million ETH, worth about $11.82 billion. BitMine aims to accumulate 5% of ETH's circulating supply.

NFP preview: Complex data release will determine if Fed was right to cut rates

The long wait is over, and the Bureau of Labor Statistics in the US will release nonfarm payrolls reports for both November and October at 1330 GMT on Tuesday. The overall NFP figure for October is expected to be -10k, however, it is expected to be influenced by a massive 130k drop in federal department workers. 

Solana Price Forecast: SOL consolidates as spot ETF inflows near $1 billion signal institutional dip-buying

Solana (SOL) price hovers above $131 at the time of writing on Monday, nearing the upper boundary of a falling wedge pattern, awaiting a decisive breakout.